Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Gross Margin: 2020-2023

Historic Gross Margin for Candel Therapeutics (CADL) over the last 4 years, with Dec 2023 value amounting to 100.00%.

  • Candel Therapeutics' Gross Margin changed negligibly% to 100.00% in Q4 2023 from the same period last year, while for Dec 2023 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • Candel Therapeutics' Gross Margin amounted to 100.00% in Q4 2023, which was down 0.00% from 100.00% recorded in Q3 2023.
  • Over the past 5 years, Candel Therapeutics' Gross Margin peaked at 100.00% during Q2 2020, and registered a low of 100.00% during Q2 2020.
  • For the 3-year period, Candel Therapeutics' Gross Margin averaged around 100.00%, with its median value being 100.00% (2023).